The Human Medicines Regulations 2012 – …

The Human Medicines Regulations 2012 – description of each Part This document provides a brief overview of each Part of the Human Medicines Regulations 2012 …

  Human, Regulations, Descriptions, Medicine, 2012, Human medicines regulations 2012, Human medicines regulations 2012 description of

FULTIUM -D 800 IU CAPSULES - GOV.UK

Vitamin D deficiency, with levels of 25(OH)D below 25nmol/L (10ng/ml), could result in the disease rickets (or osteomalacia). The disease resulting as a deficiency is considered to be due to malabsorption

  Deficiency, Capsule, Vitamin, Fultium d 800 iu capsules, Fultium, Vitamin d deficiency

GLYCOPYRRONIUM BROMIDE 0.2MG/ML …

UKPAR Glycopyrronium Bromide 0.2 mg/ml Solution for Injection PL 00156/0115 1 GLYCOPYRRONIUM BROMIDE 0.2MG/ML SOLUTION FOR INJECTION (PL 00156/0115)

  Solutions, Injection, 0115, Solution for injection pl 00156, 00156, Solution for injection, Pl 00156

Meloxicam - GOV.UK

PL 31388/0003-4 UKPAR Alpex Pharma (UK) Ltd, Meloxicam 7.5mg and 15mg Orodispersible Tablets 3 Scientific Discussion INTRODUCTION Based on the review of the data on quality, safety and efficacy, the UK granted

  15mg, Meloxicam

PL 00010/0643 - GOV.UK

UKPAR Canesten HC Cream PL 00010/0643 6 All excipients comply with their respective European Pharmacopoeia monographs, except triceteareth-4-

  Excipients, 3460, Pl 00010 0643, 00010

Public Assessment Report UKPAR Canesten Combi …

This is a summary of the Public Assessment Report (PAR) for Canesten Combi Pessary & External Cream 500mg / 2% w/w pessary & cream (PL 00010/0653).

DCPAR for Ampicillin-Salbactam 1 g--0 5 and 2 g-1 g ...

PAR Ampicillin/Sulbactam 1 g/0.5 g and 2 g/1 g powder for Solution for Injection or Infusion UK/H/4322/001-2/DC 1 Public Assessment Report Decentralised Procedure

  Solutions

Public Assessment Report Mutual Recognition …

PAR Sayana 104mg/0.65ml Suspension for Injection UK/H/0960/001/MR 1 Public Assessment Report Mutual Recognition Procedure SAYANA 104MG/0.65ML SUSPENSION FOR INJECTION

  Assessment, Report, Public, Procedures, Mutual, Recognition, Public assessment report mutual recognition, Public assessment report mutual recognition procedure

Cefixime 400 mg Film-coated Tablets, PL 22805 …

MHRA PAR; CEFIXIME 400 MG FILM-COATED TABLETS, PL 22805/0032-3 2 Lay summary The Medicines and Healthcare products Regulatory Agency …

  Cefixime

Public Assessment Report Decentralised Procedure …

Public Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC

  Assessment, Report, Public, Procedures, Public assessment report decentralised procedure, Decentralised

Datasheet Methotrexate Injection - Medsafe

Data Sheet – New Zealand Hosp 2.0 1 DBL® METHOTREXATE INJECTION AND TABLETS Name of medicine Methotrexate BP Presentation DBL® Methotrexate Injection is a sterile solution of Me thotrexate BP in Water for Injections BP. Sodium chloride is included for isotonicity except in the 1 g/10 mL vial.

  Datasheet, Injection, Methotrexate, Datasheet methotrexate injection, Me thotrexate, Thotrexate

DRUG NAME: Methotrexate - BC Cancer

Methotrexate can induce a spontaneous abortion in pregnant women especially if given in the first trimester. Methotrexate therapy may result in impairment of fertility, oligospermia, and menstrual dysfunction in

  Name, Drug, Drug name, Methotrexate

PACKAGE LEAFLET: INFORMATION FOR THE USER …

Page 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE USER Methotrexate 2.5 mg Tablets Read all of this leaflet carefully before you …

  Information, User, Leaflet, Packages, Package leaflet, Information for the user, Methotrexate, Information for the user methotrexate

methotrexate gp guidelines 2008 - Royal National …

Methotrexate J. Special clinical circumstances: (1) Alcohol: Any patient suspected of alcohol abuse is usually unsuitable for methotrexate therapy. Rheumatologists should advise the patients receiving methotrexate to limit their

  Guidelines, 2008, Methotrexate, Methotrexate gp guidelines 2008

Methotrexate for Use in Pediatric Populations

2 Methotrexate is also polyglutamated within the cell. Polyglutamation of methotrexate within the cell by the enzyme folyl polyglutamate synthetase increases the anti-proliferative effects

  Pediatric, Population, Methotrexate, Methotrexate for use in pediatric populations